Back to Journals » Breast Cancer: Targets and Therapy » Volume 7

Optimal delivery of male breast cancer follow-up care: improving outcomes

Authors Ferzoco R, Ruddy K

Received 23 July 2015

Accepted for publication 28 August 2015

Published 23 November 2015 Volume 2015:7 Pages 371—379


Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Tuhin Das

Peer reviewer comments 2

Editor who approved publication: Professor Pranela Rameshwar

Raina M Ferzoco, Kathryn J Ruddy

Department of Oncology, Mayo Clinic, Rochester, MN, USA

Abstract: Male breast cancer is a rare disease. There are limited data to inform optimal treatment and follow-up strategies in this population. Currently, most follow-up guidelines are drawn from the vast literature on female breast cancer, despite the fact that male breast cancer has unique biological characteristics. In this review, we discuss clinical characteristics of male breast cancer as well as current best practices for long-term care with a focus on surveillance, screening, and treatment-related symptom management in male breast cancer survivors.

Keywords: male breast cancer, follow-up, surveillance, screening

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Readers of this article also read:

Exercise after breast cancer treatment: current perspectives

Dieli-Conwright CM, Orozco BZ

Breast Cancer: Targets and Therapy 2015, 7:353-362

Published Date: 21 October 2015

Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer

Advani P, Cornell L, Chumsri S, Moreno-Aspitia A

Breast Cancer: Targets and Therapy 2015, 7:321-335

Published Date: 22 September 2015

Triple negative breast cancer: an Indian perspective

Akhtar M, Dasgupta S, Rangwala M

Breast Cancer: Targets and Therapy 2015, 7:239-243

Published Date: 14 August 2015

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010